Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

BACKGROUND: The role of anticoagulants for the prevention of placental-mediated pregnancy complications is uncertain. OBJECTIVES: Our aim was to investigate the effectiveness of dalteparin, a low-molecular-weight heparin, in preventing the recurrence of these complications in women without thrombophilia. PATIENTS/METHODS: Between August 1 2000 and June 20 2007, 116 pregnant women with: (i)

authors

REY, E
GARNEAU, P
DAVID, M
GAUTHIER, R
LEDUC, L
MICHON, N
MORIN, F
Demers, Catherine
KAHN, SR
MAGEE, LA
RODGER, M

status

published

publication date

January 2009

has subject area

1102 Cardiorespiratory Medicine and Haematology (FoR)
1103 Clinical Sciences (FoR)
Adult (MeSH)
Cardiovascular System & Hematology (Science Metrix)
Dalteparin (MeSH)
Female (MeSH)
Fetal Death (MeSH)
Humans (MeSH)
Infant, Low Birth Weight (MeSH)
Infant, Newborn (MeSH)
Pilot Projects (MeSH)
Placenta (MeSH)
Pre-Eclampsia (MeSH)
Pregnancy (MeSH)
Pregnancy Complications (MeSH)
Pregnancy Outcome (MeSH)
Secondary Prevention (MeSH)

published in

Journal of Thrombosis and Haemostasis Journal